Clinical Trial

A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B

Name: A Study to Evaluate AHB-137 Injection in Treatment-naïve Participants With Chronic Hepatitis B — clinical trial record (NCT07635186)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a randomized, double-blind, placebo-controlled, multicenter phase 2 study to assess the efficacy and safety of AHB-137 injection in treatment-naïve participants with chronic hepatitis B.

Trial Details

NCT Number	NCT07635186
Lead Sponsor	Ausper Biopharma Co., Ltd.
Conditions	Chronic Hepatitis B
Enrollment	320 participants
Start Date	2026-06-20
Primary Completion	2027-06-20 (estimated)
Study Completion	2028-06-20 (estimated)
Updated on ClinicalTrials.gov	2026-06-09